Already inside the gate: the company is specified into someone else's next wave, and the wave has not yet shipped
The model's full reasoning — Q4 2022 call → NOWe need answer YES/NO. Need analyze transcript. Question asks if management describes company already chosen/specified/qualified/designed into another organization's future product/program/platform/build-out/standard operating plan, such that when outside party's next wave arrives, company's volume arrives automatically, and position secured today while wave not yet shipped/launched/ramped. Need use only transcript. Need identify if any such situation described. Let's parse. Regeneron is large pharma. They have collaborations: Sanofi, Bayer, Roche, Alnylam, Intellia, Decibel. Need see if management describes being "inside someone else's next thing" with wave ahead. Possible candidates: aflibercept 8 mg? No, that's own product. Dupixent? Collaboration with Sanofi, but not "inside someone else's next thing" - it's co-developed/commercialized. Libtayo acquired rights. Collaborations with Alnylam: siRNA therapeutics for NASH, CNS. Regeneron Genetics Medicine collaboration. They are developing treatments. Is Regeneron "inside Alnylam's next thing"? Actually collaboration, both parties. Not clear. Gene therapy with Decibel: DB-OTO, virally delivered gene therapy to restore hearing. Regeneron collaborator? "our collaborators at Decibel Therapeutics recently announced that a clinical trial has been authorized... Phase 1/2 expected to initiate... initial data anticipated..." This is a product in development, not yet approved. But is Regeneron "chosen, specified, qualified" inside Decibel's product? It's a collaboration, not a supplier relationship. Also wave not arrived. But is position secured? Not exactly. Question asks "another organization's future product, program, platform, build-out, or standard operating plan" - e.g., company's product designed into larger company's upcoming offering. Regeneron is a pharma with own products. Could be "aflibercept 8 mg" as standard of care? No. Need look for management describing "we have been selected/qualified" etc. They mention "we are planning regulatory submissions" etc. Not. Maybe "next-generation COVID-19 antibody" - no. Maybe "Dupixent" in COPD? No. Maybe "Libtayo" with Sanofi? No. Maybe "Regeneron Genetics Medicine" with Alnylam: "we are planning a broad and multi-pronged approach to develop treatments for NASH... initiating Phase 2 study of ALN-HSD...
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| CLGN | CollPlant Biotechnologies Ltd. | Q4 2023 | 2024-04-04 | F |
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| AIRG | Airgain, Inc. | Q3 2023 | 2023-11-09 | F |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| WYY | WidePoint Corporation | Q3 2016 | 2016-11-09 | D |
| THRM | Gentherm Incorporated | Q2 2016 | 2016-07-28 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| SPR | Spirit AeroSystems Holdings, Inc. | Q1 2016 | 2016-04-29 | D |
CUBI · Q3 2018 → YESThe question is about whether management describes that the company has already been chosen or locked into another organization's future product/program, such that volume will come automatically when ...NO The transcript describes a white-label partnership with T-Mobile where BankMobile provides services under T-Mobile's brand, with deposits expected to start in the next year after the launch. However, this does not meet the criteria for a secured position inside T-Mobile's next product or program. The language focuses on a partnership relationship that is still being launched, rather than a design win or qualification already embedded in T-Mobile's future offering. Management refers to it as an "expected white label partnership" and "working on" the launch, indicating it is not yet locked in as part of T-Mobile's committed plan.
EMKR · Q4 2023 → YESThe question is about whether management describes that the company has already been chosen or locked into another organization's future product/program, such that volume will come automatically when ...NO The transcript describes an agreement with Kratos for Inertial Navigation Systems to be included in the XQ58 Valkyrie drone, with the Air Force planning to acquire at least 1,000 units. However, this is framed as an announcement of a new agreement rather than a secured, locked-in position already designed 100% into the platform with volume guaranteed.
NC · Q1 2024 → YESThe question is about whether management describes that the company has already been chosen or locked into another organization's future product/program, such that volume will arrive automatically whe...